These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1145574)

  • 1. [Drug treatment of hyperkinesis and mental changes caused by levodopa].
    Presthus J
    Tidsskr Nor Laegeforen; 1975 Jun; 95(16):1009-10. PubMed ID: 1145574
    [No Abstract]   [Full Text] [Related]  

  • 2. [L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments].
    Vasin NIa; Il'inskiĭ IA; Safronov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(5):701-6. PubMed ID: 4454895
    [No Abstract]   [Full Text] [Related]  

  • 3. [Madopar in the treatment of paralysis agitans. I. Therapeutic efficacy and side-effects in 56 cases (author's transl)].
    Liu DK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980; 13(3):147-50. PubMed ID: 7438902
    [No Abstract]   [Full Text] [Related]  

  • 4. L-tryptophan in the treatment of levodopa induced psychiatric disorders.
    Miller EM; Nieburg HA
    Dis Nerv Syst; 1974 Jan; 35(1):20-3. PubMed ID: 17894051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reports on mental disorders in Parkinson disease in relation to treatment with L-dopa].
    Agostino R; Fabri S
    Riv Neurobiol; 1983; 29(4):577-84. PubMed ID: 6678478
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of psychopharmaceutical agents in children].
    Minderaa RB; Intveld AN; Vink HJ
    Ned Tijdschr Geneeskd; 1989 Feb; 133(5):252-6. PubMed ID: 2927536
    [No Abstract]   [Full Text] [Related]  

  • 7. [L dopa and mental disorders].
    Castaigne P
    Int J Neurol; 1975; 10(1-4):178-85. PubMed ID: 1181309
    [No Abstract]   [Full Text] [Related]  

  • 8. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A; Grau-Veciana JM
    Med Clin (Barc); 1985 Jun; 85(3):88-91. PubMed ID: 4021630
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in the administration of L-DOPA (author's transl)].
    Ferrari E
    Riv Patol Nerv Ment; 1974 Aug; 95(4):239-50. PubMed ID: 4283417
    [No Abstract]   [Full Text] [Related]  

  • 10. Personal experience with a combination of drugs in subjects with dopa resistant Parkinson's disease.
    Mastrosimone F; Colucci d'Amato C; De Angelis G; Iaccarino C; Giordano L; Marmo E
    J Med; 1980; 11(5-6):377-83. PubMed ID: 6962824
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic agonist-induced hypersensitivity and on-off hyperkinesis.
    Goetz CG; Klawans HL
    Ann Neurol; 1979 Sep; 6(3):277-8. PubMed ID: 534431
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinsonism, levodopa, and intelligence.
    Loranger A; Sweet RD; Goodell H; McDowell F
    Int J Neurol; 1975; 10(1-4):276-81. PubMed ID: 1181314
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy.
    Botez MI; Barbeau A
    Int J Neurol; 1975; 10(1-4):222-32. PubMed ID: 1181311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mental disorders in patients with Parkinson's disease treated with L-dopa].
    Piccirilli M; Piccinin GL
    Clin Ter; 1981 Jun; 97(5):473-9. PubMed ID: 7273659
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychiatric complications of L-dopa: physiopathology and treatment].
    Castro-García A
    Rev Neurol; 1997 Aug; 25 Suppl 2():S157-62. PubMed ID: 9280683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mental disorders in the course of L-dopa treatment].
    Reichowa J; Goldsztajn M
    Psychiatr Pol; 1973; 7(1):87-9. PubMed ID: 4715838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Idiopathic Parkinson's disease].
    Vieregge P
    Fortschr Neurol Psychiatr; 2008 Feb; 76(2):114-22; quiz 123-6. PubMed ID: 18256971
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].
    Cinca I; Serbănescu A; Tudorache B
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):261-70. PubMed ID: 6222452
    [No Abstract]   [Full Text] [Related]  

  • 19. Mental disorders in Parkinson's disease after treatment with L-DOPA.
    Rondot P; de Recondo J; Coignet A; Ziegler M
    Adv Neurol; 1984; 40():259-69. PubMed ID: 6695602
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
    Olsson JE; Duchek M; Ekberg R; Fehling C; Johansson F; Johnels B; Lindvall B; Nordin G; Sidén A; Steg G
    Lakartidningen; 1993 Apr; 90(16):1545-8. PubMed ID: 8483351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.